Columns

MS news notes: Ocrevus, MDX-2201, online cannabis clinic, WHO

Welcome to ā€œMS News Notes,ā€ a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Study shows Ocrevus lowers risk of MS progression This seems to be just what the doctor ordered,…

Reflections from the front line: Dying, an atheist (a)muses

If you noticed my sudden disappearance, it wasn’t because I was sacked. Surprising, I know. Just “MS MIA” ā€” missing in action with multiple sclerosis. While raving in the hospital, I was suddenly moved to my own private room. In Britainā€™s National Health Service (NHS), this could only mean…

MS News Notes: Briumvi, vitamin D, CNM-Au8

Welcome to ā€œMS News Notes,ā€ a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. In this column, Iā€™ll be highlighting more MS News Today articles from the Americas Committee for Treatment and Research in Multiple Sclerosis…

MS news notes: Evobrutinib, a portable MRI, fatigue, depression

Welcome to ā€œMS News Notes,ā€ a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. In this column, I’ll be highlighting some MS News Today stories from last week’s Americas Committee for Treatment and Research in Multiple Sclerosis…

Thankful for caregivers: What MS has taught me about support

Itā€™s been a couple weeks since my last column, and things with my mother have proven more challenging than we expected. Sheā€™s had another minor procedure to stop fluid from building up in her chest, but she is progressing with her rehab and continues to gain strength. Hopefully, weā€™ll…

MS news notes: Remyelination, CNM-Au8, diet and bones

Welcome to ā€œMS News Notes,ā€ a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: More remyelination research For years, most MS research has focused on stopping disease progression. In the past couple…

After 3 years, COVID-19 finally caught up to me

It was bound to happen. Even though it’s been more than three years since COVID-19 reared it head in Wuhan, China, and even though I’ve had five of the COVID-19 vaccine shots recommended by the U.S. Centers for Disease Control and Prevention ā€” two primary series doses and three…

MS news notes: Tysabri biosimilar, diet, cognitive rehab, aging

Welcome to ā€œMS News Notes,ā€ a weekly Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Tysabri biosimilar on the horizon Tysabri (natalizumab) is a very effective disease-modifying therapy (DMT) for…

A Primer on ABLE Accounts for Americans With Disabilities

Have you ever heard of an ABLE savings account? I hadn’t until a couple weeks ago. The acronym stands for the Achieving a Better Life Experience Act, a law passed by the U.S. Congress in 2014. It created special savings accounts that allow disabled Americans, including people with…